The observation that all treatments were able to alter cytokine and ICAM-1 mRNA expression levels in vivo but not in vitro suggest that the interplay between various cell types is crucial for the effect in experimental glomerulonephritis. Here, ICAM1 is linked to glomerulonephritis.